【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 7
1.1 List of Tables 13
1.2 List of Figures 15
2 Introduction 18
2.1 Report Scope 18
2.2 Upcoming Related Reports 19
2.3 Recently Published Reports 19
3 US Private Equity and Venture Capital Industry Dynamics 21
3.1 Post-2008 Financial Market Crash: Volume of Capital Commitments to Private Equity Funds Show Signs of Recovery 21
3.1.1 Venture Capital Fundraising Trend in the US 22
3.2 Volume over Value: Decrease in the Average Value of Completed Private Equity Healthcare Deals between 2007 and 2013 24
3.3 Healthcare Reform and Cost Pressures in Europe and North America Shifts Deal Activity to the Asia-Pacific Region 25
3.4 Private Equity Deals by Therapy Area 28
3.4.1 Central Nervous System, Immunology, Infectious Disease, Metabolic Disorders, and Oncology Enjoying Significant Investment 28
3.5 Private Equity Buyouts of 2013 30
3.6 Venture Capital Investment Trend 31
3.7 Venture Capital Investment: Biotechnology Plays Second Fiddle to Software 34
3.8 Seed-Stage Financing Shows Downward Trend 37
3.9 Venture-Backed Exits in 2013 38
3.9.1 Significant Venture-Backed Biotechnology Acquisitions in 2013 40
3.9.2 Venture-Backed Mergers and Acquisition Witness Strong End to 2013 40
3.10 California, Massachusetts, and New York Lead the Pack in Venture Capital Investment for 2013 42
4 Equity Offerings 44
4.1 Equity Offerings in the Healthcare Sector 44
4.2 Venture-Backed Initial Public Offerings in 2013 45
4.3 Venture-Backed Emerging Biotech Initial Public Offerings in 2013 46
4.4 Liquidity Position Makes Emerging Biotechs an Attractive Prospect for Investors 47
4.5 Company Profiles and Initial Public Offer Details 49
4.5.1 Intrexon Corporation (Stock Symbol: XON) 49
4.5.2 Ophthotech Corporation (Stock Symbol: OPHT) 51
4.5.3 PTC Therapeutics (Stock Symbol: PTCT) 52
4.5.4 Portola Pharmaceuticals (Stock Symbol: PTLA) 54
4.5.5 Agios Pharmaceuticals (Stock Symbol: AGIO) 55
4.5.6 Chimerix (Stock Symbol: CMRX) 57
4.5.7 Bluebird Bio (Stock Symbol: BLUE) 58
4.5.8 Foundation Medicine (Stock Symbol: FMI) 59
4.5.9 OncoMed Pharmaceuticals (Stock Symbol: OMED) 60
4.5.10 Acceleron Pharma (Stock Symbol: XLRN) 62
4.5.11 Prosensa Therapeutics (Stock Symbol: RNA) 64
4.5.12 Epizyme (Stock Symbol: EPZM) 65
4.5.13 Onconova Therapeutics (Stock Symbol: ONTX) 66
4.5.14 Tetraphase Pharmaceuticals (Stock Symbol: TTPH) 68
4.5.15 Esperion Therapeutics (Stock Symbol: ESPR) 69
5 Private Equity Firms: Company Drill-Downs 71
5.1 Section Overview 71
5.2 TPG Capital 72
5.2.1 Overview and Portfolio Management 72
5.2.2 Historical Deals Trend 74
5.2.3 Healthcare-Related Deals in 2013 76
5.3 The Carlyle Group 76
5.3.1 Overview and Portfolio Management 76
5.3.2 Historical Deals Trend 78
5.3.3 Healthcare-Related Deals in 2013 79
5.4 The Blackstone Group 80
5.4.1 Overview and Portfolio Management 80
5.4.2 Historical Deals Trend 82
5.4.3 Healthcare-Related Deals in 2013 83
5.5 Kohlberg Kravis Roberts 83
5.5.1 Overview and Portfolio Management 83
5.5.2 Historical Deals Trend 86
5.5.3 Healthcare-Related Deals in 2013 88
5.6 Warburg Pincus 89
5.6.1 Overview and Portfolio Management 89
5.6.2 Historical Deals Trend 90
5.6.3 Healthcare-Related Deals in 2013 92
5.7 Goldman Sachs Principal Investment Area 93
5.7.1 Overview and Portfolio Management 93
5.7.2 Historical Deals Trend 93
5.8 Advent International Corporation 95
5.8.1 Overview and Portfolio Management 95
5.8.2 Historical Deals Trend 96
5.8.3 Healthcare-Related Deals in 2013 98
5.9 Apollo Global Management 99
5.9.1 Overview and Portfolio Management 99
5.9.2 Healthcare-Related Deals in 2013 99
5.10 Bain Capital 99
5.10.1 Overview and Portfolio Management 99
5.10.2 Historical Deals Trend 100
5.10.3 Healthcare-Related Deals in 2013 101
5.11 CVC Capital Partners 101
5.11.1 Overview and Portfolio Management 101
5.11.2 Historical Deals Trend 102
5.12 Oaktree Capital Management 103
5.12.1 Overview and Portfolio Management 103
5.12.2 Historical Deals Trend 104
5.13 Hellman & Friedman 105
5.13.1 Overview and Portfolio Management 105
5.13.2 Historical Deals Trend 106
6 Venture Capital Firms: Company Drill-Downs 108
6.1 Section Overview 108
6.2 New Enterprise Associates 109
6.2.1 Overview and Portfolio Management 109
6.2.2 Historical Deals Trend 112
6.2.3 Biotechnology Exits and Initial Public Offerings in 2013 114
6.3 OrbiMed Advisors 115
6.3.1 Overview and Portfolio Management 115
6.3.2 Historical Deals Trend 117
6.3.3 Biotechnology Exits and Initial Public Offerings in 2013 119
6.4 Canaan Partners 120
6.4.1 Overview and Portfolio Management 120
6.4.2 Historical Deals Trend 122
6.4.3 Biotechnology Exits and Initial Public Offerings in 2013 123
6.5 Versant Ventures 123
6.5.1 Overview and Portfolio Management 123
6.5.2 Historical Deals Trend 125
6.5.3 Biotechnology Exits and Initial Public Offerings in 2013 127
6.6 New Leaf Venture Partners 128
6.6.1 Overview and Portfolio Management 128
6.6.2 Historical Deals Trend 129
6.6.3 Biotechnology Exits and Initial Public Offerings in 2013 131
6.7 Third Rock Ventures 132
6.7.1 Overview and Portfolio Management 132
6.7.2 Historical Deals Trend 134
6.7.3 Biotechnology Exits and Initial Public Offerings in 2013 136
6.8 Domain Associates 137
6.8.1 Overview and Portfolio Management 137
6.8.2 Historical Deals Trend 139
6.8.3 Biotechnology Exits and Initial Public Offerings in 2013 141
6.9 Kleiner Perkins Caufield & Byers 142
6.9.1 Overview and Portfolio Management 142
6.9.2 Historical Deals Trend 144
6.9.3 Biotechnology Exits and Initial Public Offerings in 2013 146
6.10 Clarus Ventures 147
6.10.1 Overview and Portfolio Management 147
6.10.2 Historical Deals Trend 148
6.10.3 Biotechnology Exits and Initial Public Offerings in 2013 150
6.11 Flagship Ventures 151
6.11.1 Overview and Portfolio Management 151
6.11.2 Historical Deals Trend 153
6.11.3 Biotechnology Exits and Initial Public Offerings in 2013 155
6.12 Additional Venture Capital Firms with Significant Biotechnology Investments 156
6.12.1 Novo A/S 156
6.12.2 InterWest Partners 158
6.12.3 Essex Woodlands Health Ventures 160
6.12.4 Alta Partners 162
6.12.5 Third Security 164
7 Strategic Outlook 166
7.1 New Financing Models Needed for Sustainable Growth of Emerging Biotechs 166
7.2 Aggressive Growth Will Continue in the Asia-Pacific Region 167
7.3 Small and Midsize Funds Will Enjoy Significant Deal Activity 167
7.4 Initial Public Offering Activity Will Increase in 2014 168
7.5 Increased Pressure on Venture Capital Firms 168
8 Appendix 169
8.1 Bibliography 169
8.2 Abbreviations 174
8.3 Research Methodology 178
8.3.1 Coverage 178
8.3.2 Secondary Research 178
8.3.3 Expert Panel Validation 179
8.4 About the Authors 180
8.4.1 Analyst 180
8.4.2 Director of Healthcare Industry Dynamics 180
8.4.3 Global Head of Healthcare 181
8.5 About the Industry Dynamics Team 181
8.6 About GlobalData 182
8.7 Disclosure Information 182
8.8 Disclaimer 182
【レポート販売概要】
■ タイトル：バイオ技術投資レポート：プライベート・エクイティ及びベンチャーキャピタル投資動向■ 英文：PharmaSphere: Emerging Biotech Investment Report - Strategic Trends in Private Equity and Venture Capital Funding
■ 発行日：2014年3月12日
■ 調査会社：GlobalData
■ 商品コード：GDHC005PSR
■ 調査対象地域：グローバル
- 外科手術用封止剤・接着剤の世界市場予測（～2021年）：天然、合成、フィブリン、コラーゲン、ゼラチン、シアノアクリル酸、アルブミン、人血The surgical sealants market is expected to witness a significant growth in the coming years. Factors such as the growing need to control blood loss in patients during surgeries, growth in the number of surgeries, rising geriatric population coupled with the increasing prevalence of chronic disorders, and the increasing uptake of technologically advanced products owing to the FDA and CE Mark appro …
- 機能性タンパク質の世界市場予測（～2022年）：加水分解物、ホエータンパク質濃縮物、ホエータンパク質分離物、カゼイン、大豆プロテインThe functional proteins market is projected to grow at a CAGR of 6.6%, in terms of value, from 2017 to reach USD 5.73 Billion by 2022. Functional proteins are widely used in food & beverage applications owing to their functional properties. Also, the growing demand for high-protein & nutritious products and an increase in the demand for premium-protein ingredients have expanded the application are …
- オフショア支援船の世界市場2019-2023About this market The rise in deepwater and ultra-deepwater E&P activities will drive the offshore support vessel market growth in the forthcoming years. Oil and gas upstream companies have been extracting oil and gas from onshore locations for some years. This has further resulted in the rising investments in offshore E&P activities in deepwater and ultra-deepwater locations while increasing the …
- 韓国の麻酔装置・呼吸装置市場South Korea Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain Management Devices, Regional Anesthesia Disposables, Respiratory Devices, Respiratory Disposables and Others Summary GlobalData’s new report, "South Korea Anesthesia and Respiratory Devices Market Outlook to 2021 - Airway and Anesthesia Devices, Anesthesia Machines, Pain …
- 世界の動物医療市場This report provides a worldwide strategic overview of the animal health market, including: • Five-year forecasts for: - Major market segments - Key geographic regions • Assessment of major U.S. and international trends with potentially significant impact on the animal health industry during the next five years, including discussion of su …
- 世界の銀行業界におけるIT支出市場動向（2012-2016）TechNavio's analysts forecast the Global Banking IT Spending market to grow at a CAGR of 3.51 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for risk management systems. The Global Banking IT Spending market has also been witnessing the increasing use of social media as a marketing tool. However, cyber security issues could pos …
- 産業用塗装の世界市場2016-2020About Industrial Coatings Industrial coatings are used on the surfaces of steel, aluminum, wood, and plastic for protection from external factors such as fire, moisture, and corrosion. They are also used for aesthetic purposes. These coatings are used in a wide range of industries, including automotive, construction, and electronics, and are available in four different forms: liquid, powder, pretr …
- 商用冷却の世界市場2016-2020：商用ウォークインクーラー、商用冷蔵ショーケース、飲料用冷蔵庫、製氷機About Commercial Refrigeration Refrigeration is used to preserve perishable food items and ensure food safety. The products offered in the global commercial refrigeration market find application in the commercial, industrial, and residential sectors. The market for commercial registration equipment is driven by regulatory standards on labeling, energy performance, refrigerants, and others. The glo …
- 世界のGas-to-Liquid（ガス・トゥー・リキッド）市場In the wake of the rising pollution levels due to the emissions traditionally associated with conventional petroleum-fuelled and diesel-fuelled vehicles, Gas to liquids technology is forecast to advance rapidly. Gas to liquids technology (GTL) provides crystal clear fuels that can dramatically improve air quality in the major metropolitan areas of the world. GTL uses natural gas as a raw material …
- アルミニウム押出製品の世界市場：圧延仕上アルミ、アルマイト、粉体塗装アルミAluminum extrusions are used for their strength, flexibility, durability and sustainability in various sectors such as construction, transportation, electrical, machinery and consumer durables. They are 100% recyclable and emits no significant hazardous gasses during processing. The increased usage in green initiatives is driving the growth of the aluminum extrusion market. Technavios market resea …
- 宇宙状況把握（SSA）の世界市場予測（～2023年）The space situational awareness market is estimated to be USD 1.15 Billion in 2018 and is projected to reach USD 1.44 Billion by 2023, at a CAGR of 4.54% from 2018 to 2023. The growth of the space situational awareness market is driven by several factors, including the growing congestion of objects in the space, and the focus of government agencies and private entities on space situational awarene …
- Enbrel (Psoriasis)：市場予測と分析（～2022）Enbrel (Psoriasis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, “Enbrel (Psoriasis) - Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Psoriasis (PsO), so this remains at the top of the list for unmet needs. While physicians agree that biologics are relatively safe and effective, these therap …
- 中東のクラウドインフラサービス市場予測（～2021）The Middle East cloud infrastructure services market is expected to grow from USD 2.31 Billion in 2016 to USD 7.46 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 26.4% during the forecast period. The major growth drivers of the market include easy access to disaster recovery, faster deployment of infrastructure services & scalability features, enhanced efficiency & business productivi …
- サーモクロミック材料の世界市場分析The global thermochromic materials market is expected to reach USD 7.31 Billion by 2025, according to a new report by Grand View Research, Inc. Growing demand for reversible thermochromic materials in application industries is expected to drive demand over the forecast period. Growing demand for thermochromic materials in food quality indicators to determine the quality of frozen meat and dairy pr …
- ドメインネームシステム（DNS）ツールの世界市場2016-2020About Domain Name System Tools DNS is a decentralized naming system for computers, services, or any resource connected to the Internet or a private network. It consists of various information with domain names assigned to each of the participating entities. It translates the domain names into the numerical Internet protocol (IP) addresses required for identifying computer services and devices with …
